Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Evotec SE

Start price
Target price
Perf. (%)
€17.95
28.11.23
€28.00
28.11.25
2.06%
11.12.23

Covacoro 
28.11.23 90%
buy
M1 Kliniken AG

Start price
Target price
Perf. (%)
€6.04
09.12.22
-
09.12.23
68.87%
10.12.23

DirectorDealer 
09.12.22 50%
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€17.06
26.11.23
-
26.11.24
57.74%
09.12.23

Could be worthwhile Investment >10% per year
melinda 
26.11.23 10%
buy
Bayer AG

Start price
Target price
Perf. (%)
€31.93
08.12.23
-
08.12.24
0.11%
08.12.23

Could be very worthwhile Investment >20% year
bundfuture 
08.12.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€34.23
20.11.23
€42.00
20.11.24
-6.50%
07.12.23

Undervalued
Well known brand
Future proof or reliable business model
Top 10 in its market
Snowman 
20.11.23 50%
buy
Medigene AG

Start price
Target price
Perf. (%)
€2.29
06.12.22
-
06.12.23
-33.62%
07.12.23

DirectorDealer 
06.12.22 50%
buy
Gerresheimer AG

Start price
Target price
Perf. (%)
€72.50
02.12.22
-
02.12.23
22.69%
03.12.23

Lutz69 
02.12.22 50%
sell
Bayer AG

Start price
Target price
Perf. (%)
€32.77
24.11.23
€35.00
21.12.23
-6.78%
29.11.23

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Traumtanz 
24.11.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€33.84
21.11.23
€35.00
21.12.23
-3.16%
24.11.23

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Traumtanz 
21.11.23 50%
sell
Bayer AG

Start price
Target price
Perf. (%)
€40.83
15.11.23
€35.00
15.11.24
-19.02%
22.11.23

Probably not worthwhile Investment
Higher risks for its business
kschabe 
15.11.23 60%
buy
Bayer AG

Start price
Target price
Perf. (%)
€52.39
07.08.23
€54.00
07.08.24
-35.42%
21.11.23

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Traumtanz 
07.08.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€40.81
31.10.23
-
31.10.24
-18.31%
20.11.23

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Growths faster than the competition
Significant cyclical dependencies
fenjal 
31.10.23 50%
sell
Sartorius AG VZO

Start price
Target price
Perf. (%)
€396.90
15.11.22
-
15.11.23
-30.86%
16.11.23

DirectorDealer 
15.11.22 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€19.00
12.11.22
€25.00
12.11.23
-7.37%
12.11.23

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Innovative
Some uniques
Maxfloh 
12.11.22 0%
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€0.96
11.11.23
-
11.11.24
-
11.11.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Taurito 
11.11.23 0%
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€0.81
05.11.23
-
05.11.24
15.43%
11.11.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Taurito 
05.11.23 0%
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€1.01
03.09.23
-
03.09.24
-19.80%
05.11.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Taurito 
03.09.23 0%
buy
B.R.A.I.N. Biotechnology Research and Information Network AG

Start price
Target price
Perf. (%)
€4.98
13.10.22
-
13.10.23
-18.27%
14.10.23

DirectorDealer 
13.10.22 50%
sell
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€38.99
04.10.23
€22.00
04.10.24
-16.75%
14.10.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
kostojunior 
04.10.23 0%
buy
Vita 34 AG

Start price
Target price
Perf. (%)
€4.76
19.09.23
€6.00
19.09.24
-1.68%
30.09.23

Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
kostojunior 
19.09.23 30%
buy
Vita 34 AG

Start price
Target price
Perf. (%)
€4.79
07.09.23
-
07.09.24
-4.59%
16.09.23

Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
kostojunior 
07.09.23 70%
sell
Paion AG

Start price
Target price
Perf. (%)
€0.90
08.09.22
€0.000
08.09.23
-24.53%
09.09.23

Innovative
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Strong uniques
kostojunior 
08.09.22 0%
sell
ifa systems AG

Start price
Target price
Perf. (%)
€3.16
20.08.23
€0.000
20.08.24
-5.70%
03.09.23

Revenue decline/stagnation expected
Decining EBIT margin than peer group
EBIT decline/stagnation expected
High valuation
dimontalban 
20.08.23 70%
buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€34.35
22.12.22
-
22.12.23
13.25%
24.08.23

Finanzoo 
22.12.22 50%
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€1.28
06.08.23
-
06.08.24
-12.50%
20.08.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Taurito 
06.08.23 0%